Last reviewed · How we verify
NCT07456631: ACTsocially
ACTsocially: The (Dis)Similarities of ACT for Changing Internalizing and Externalizing Symptomatology in Adolescence
NA trial testing ACTsocially in Social Anxiety Disorder (SAD) in 54 participants. Currently enrolling.
30 September 2027
Quick facts
| Lead sponsor | University of Coimbra |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 54 |
| Start date | 1 September 2023 |
| Primary completion | 30 September 2027 |
| Estimated completion | 30 September 2027 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- ACTsocially
Conditions studied
- Social Anxiety Disorder (SAD) — all drugs for Social Anxiety Disorder (SAD) →
- Oppositional Defiant Disorder — all drugs for Oppositional Defiant Disorder →
Sponsor
University of Coimbra
Who can join
Adults 12 to 18, any sex, with Social Anxiety Disorder (SAD) or Oppositional Defiant Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Social functioning, fundamental to adolescent's development and mental health, may be impaired by polarizing problematic social functioning, namely externalizing symptoms manifested by Oppositional Defiant Disorder and internalizing symptoms portrayed by Social Anxiety Disorder. Despite their high prevalence and similar associated impairments, interventions targeting these disorders are differently conceived. Alternatively, Acceptance and Commitment Therapy (ACT) proposes that those apparently dissimilar social difficulties are rooted in similar processes. Though research has shown ACTs' efficacy in changing adults' internalizing and externalizing symptoms, studies on the potential of ACT in changing those problematics in adolescence are still scarce. This project proposes to conduct three clinical trials to test the efficacy and (dis)similarities of an transdiagnostic ACT intervention for changing internalizing and externalizing symptomatology in adolescents. It will amplify the transdiagnostic and evidence-based application of ACT to adolescents presenting polarizing disorders in the social functioning spectrum.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07456631
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Social Anxiety Disorder (SAD)
Currently open trials in the same condition.
- NCT07228143 — Stepped Care Treatment for Anxiety Resilience · NA · recruiting
- NCT07466277 — Intermittent Theta Burst Stimulation of the Prefrontal Cortex in Social Anxiety Disorder · NA · recruiting
- NCT07533812 — AI-Assisted 4-Week Psychodynamic Therapy and Cognitive Behavioral Therapy Via Smartphone for Social Anxiety: A Randomize · NA · active not recruiting
- NCT06901128 — The Covideo Study - a Trial of Cognitive Therapy for Social Anxiety Disorder in Youth, Comparing Screen to Office Delive · NA · recruiting
- NCT06805565 — A Study of ONO-1110 in Patients With Social Anxiety Disorder · Phase 2 · active not recruiting
Other University of Coimbra trials
Trials by the same sponsor.
- NCT07018089 — The Efficacy of the iWork.COMP Among Health Care Professionals · NA · not yet recruiting
- NCT07481253 — PSYCHOPATHY.COMP Program Among Male Prison Inmates With Psychopathy · NA · not yet recruiting
- NCT07296081 — ⁶⁸Ga-FAPI PET/CT for Cardiac Fibrosis in Heart Failure · recruiting
- NCT07329647 — Targeting Neurovascular Coupling in Cognitive Decline Via Nitrate-Based Supplementation · NA · recruiting
- NCT06922071 — The REMINDER4Care Program for Older Adults Supported by Residential and Daycare Facilities · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07456631 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Coimbra
- Last refreshed: 10 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07456631.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing